Bortenat Bortezomib 3.5 mg Injection

Name: Bortenat Bortezomib 3.5 mg Injection
Brand: HEET HEALTHCARE PVT. LTD.
Price: 5000 INR
Availability: InStock

Price 5000 INR/ Box

Get a Price/Quote

MOQ : 100 Boxes

Bortenat Bortezomib 3.5 mg Injection Specification

Dosage Form
As Per Suggestion

Origin
India

Feature
Other

Ingredients
Other

Application
Other

Storage Instructions
Cool & Dry Place

Shelf Life
2 Years

Bortenat Bortezomib 3.5 mg Injection Trade Information

Minimum Order Quantity
100 Boxes

FOB Port
Delhi, Mumbai

Payment Terms
Letter of Credit (L/C), Western Union, Paypal, Letter of Credit at Sight (Sight L/C), Cash Advance (CA), Telegraphic Transfer (T/T), Cash in Advance (CID), Cheque

Supply Ability
10000 Boxes Per Month

Delivery Time
7 Days

Packaging Details
Per Box 1 vial

Main Export Market(s)
Australia, North America, Eastern Europe, Middle East, Western Europe, Africa, Central America, South America, Asia

Main Domestic Market
All India

About Bortenat Bortezomib 3.5 mg Injection

Bortenat Bortezomib 3.5 mg Injection Leveraging upon our advanced production facility we provide a super quality Bortezomib for Injection 3.5 mg. The offered injections are processed with superb quality ingredients as per with internationally accepted standards. It helps to slow down the growth of cancerous cells in the body and is used for the treatment of multiple myeloma and mantle cell lymphoma. Moreover, the provided injection is clinically tested against variegated quality parameters to deliver an effective range at patrons end.

Features:

Widely used in the treatment of multiple myeloma
High medicinal value
Accurate composition

Precision Anti-Cancer Therapy

Bortenat Bortezomib 3.5 mg Injection delivers targeted therapy for cancer patients, contributing to the management of several malignancies. Its formulation is designed for maximum efficacy under professional supervision, ensuring controlled dosages and personalized treatment plans.

Safe and Simple Storage

This medication retains its stability and effectiveness when stored at room temperature (25C) in a cool, dry environment. Proper storage ensures the integrity of the active ingredient, making it suitable for various healthcare settings, including clinics and hospitals.

FAQ's of Bortenat Bortezomib 3.5 mg Injection:

Q: How should Bortenat Bortezomib 3.5 mg Injection be administered?

A: Bortenat should be administered only under the supervision of a qualified healthcare professional. The exact dosage and administration schedule will be determined by your physician based on your specific condition and response to therapy.

Q: What is the main benefit of using Bortenat Bortezomib 3.5 mg Injection?

A: Bortenat delivers precise anti-cancer activity, helping to control and manage certain types of cancer as part of a comprehensive treatment plan. Its targeted approach increases effectiveness by interfering with cancer cell growth.

Q: When should I use Bortenat Bortezomib 3.5 mg Injection?

A: The timing and frequency of Bortenat administration depend on your doctor's instructions. It is crucial to follow the prescribed schedule closely for optimal therapeutic benefit.

Q: Where should Bortenat Bortezomib 3.5 mg Injection be stored?

A: Store the injection at room temperature, ideally around 25C, in a cool and dry place away from direct sunlight. Avoid exposure to moisture and heat to maintain the medication's quality.

Q: What is the process for receiving Bortenat Bortezomib 3.5 mg Injection therapy?

A: Your physician will evaluate your medical condition and determine an appropriate dosage regimen. The injection is then administered in a clinical setting under medical supervision as per established treatment protocols.

Q: Who can provide more guidance on the dosage and usage of Bortenat Bortezomib 3.5 mg Injection?

A: A licensed healthcare provider or oncologist should be consulted for all questions related to dosage, administration, and potential side effects, as the therapy must be tailored to each individual's medical needs.

Tell us about your requirement